Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market
Healthcare Services

Increasing Prevalence Of Allergic Diseases Fueling The Growth Of The Market Amid Growing Demand For Accurate Allergy Assessment Is Supporting Development Across The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

The market for specific immunoglobulin g subclass 4 (igg4) testing has experienced rapid growth in recent years. It is projected to increase from $1.37 billion in 2025 to $1.54 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.4%. This historical growth can be attributed to increased awareness of igg4-related diseases, the expansion of diagnostic laboratory networks, the growing adoption of antibody-based diagnostics, advancements in immunoassay technologies, and rising clinical research activity.

The specific immunoglobulin g subclass 4 (igg4) testing market size is anticipated to expand significantly over the next few years, projected to reach $2.44 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2%. This expected increase during the forecast period is driven by factors such as an escalating demand for precision diagnostics, the expansion of hospital-based testing facilities, growing investments in laboratory automation, increasing adoption of advanced immunology panels, and a heightened focus on early disease detection. Key trends in this period will include the rising adoption of specialized immunoassays, an increasing demand for autoimmune disease diagnostics, the growing use of igg4 testing in clinical practice, the expansion of laboratory automation in immunology, and an enhanced emphasis on diagnostic accuracy.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30400&type=smp

Which Growth Drivers Are Expected To Support The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Forward?

The increasing prevalence of allergic conditions is anticipated to drive expansion in the specific immunoglobulin G subclass 4 (IgG4) testing market. Allergic diseases are immune-system-triggered hypersensitivity issues, encompassing conditions such as food allergies, atopic dermatitis, asthma, and allergic rhinitis, which manifest when the immune system reacts abnormally to typically harmless substances. The rise in allergic disease prevalence is attributed to shifts in dietary patterns, as increased consumption of highly processed foods can alter gut microbiota and elevate the likelihood of developing allergic sensitization. Specific IgG4 testing facilitates the assessment of immune responses linked to repeated allergen exposure, thereby supporting clinicians in understanding tolerance patterns and interpreting complex allergy-related immune activity. For instance, in May 2024, according to the Food Standards Agency (FSA), a UK-based government body responsible for food safety and public health protection, approximately 6%, or 2.4 million, of the UK adult population was found to have a clinically confirmed food allergy. Therefore, the growing occurrence of allergic diseases is a key factor propelling the specific immunoglobulin G subclass 4 (IgG4) testing market forward.

How Is The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Structured Across Different Market Segments?

The specific immunoglobulin g subclass 4 (igg4) testing market covered in this report is segmented –

1) By Product Type: Reagents And Kits, Instruments, Services

2) By Application: Allergy Diagnosis, Autoimmune Disease Diagnosis, Research, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Reagents And Kits: Purification Reagents, Detection Reagents, Assay Kits, Calibrators, Controls

2) By Instruments: Automated Analyzers, Enzyme Linked Immunoassay Readers, Microplate Washers, Sample Preparation Systems, Laboratory Automation Platforms

3) By Services: Testing Services, Validation Services, Quality Assurance Services, Custom Assay Development Services, Technical Support Services

Which Trends Are Guiding The Development Of The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

Major companies within the specialty PACS market are prioritizing product innovation, incorporating features such as artificial intelligence (AI) and machine learning (ML), to boost their market revenues. The integration of AI and ML is intended to transition the upcoming generation of Picture Archiving and Communication System (PACS) to cloud environments and enhance AI-enabled solutions for clinicians. For instance, in November 2023, Koninklijke Philips N.V., a Netherlands-based technology company, introduced HealthSuite Imaging on Amazon Web Services (AWS) with the goal of bringing the next generation of picture archiving and communication systems (PACS) to the cloud and advancing AI-enabled tools to support clinicians. This cloud-based system is engineered to allow radiologists and clinicians to more rapidly adopt new functionalities, improve operational effectiveness, and elevate patient care. By utilizing AWS, Philips aims to offer enhanced image access speeds, greater reliability, and streamlined data orchestration for healthcare professionals across the full imaging workflow, from initial treatment to follow-up. Additionally, the alliance with AWS will further develop AI in healthcare through the application of foundation models using Amazon Bedrock, designed to accelerate more accurate diagnoses and automate administrative responsibilities.

Which Organizations Are Involved In The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

Major companies operating in the specific immunoglobulin g subclass 4 (igg4) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Revvity, Randox Laboratories Ltd, NeoGenomics Laboratories Inc., ARUP Laboratories, Dr Lal PathLabs Limited, Metropolis Healthcare Ltd, ProSci Incorporated, Leinco Technologies Incorporated, MyBioSource Inc., Boster Biological Technology, PROTIA Inc., Creative Diagnostics LLC.

Access The Complete Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/global-specific-immunoglobulin-g-subclass-4-igg4-testing-market-report

Which Region Holds The Largest Share In The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

North America was the largest region in the specific immunoglobulin G subclass 4 (IgG4) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specific immunoglobulin g subclass 4 (igg4) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=30400&type=smp

Browse Through More Reports Similar to the Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market 2026, By The Business Research Company

Immunoglobulin E Ige Allergy Blood Tests Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

Immunoglobulins Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Subcutaneous Immunoglobulin Scig Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model